Orbem is a technology company.
Orbem has raised $32.0M across 1 funding round.
Orbem has raised $32.0M in total across 1 funding round.
Orbem has raised $32.0M in total across 1 funding round.
Orbem's investors include 83North, Accel, EQT Ventures, Flash Ventures, General Catalyst, Kreos Capital, La Famiglia, Octopus Ventures, Pareto Holdings, Picus Capital, Pi Labs, Vorwerk Ventures.
Orbem is a Munich-based deep tech startup that develops AI-powered imaging solutions by combining accelerated magnetic resonance imaging (MRI) with advanced deep learning algorithms. Their flagship product, the Orbem Genus, is designed primarily for the poultry industry to non-invasively classify chicken eggs before hatching, determining sex and fertility early. This innovation addresses major ethical and economic challenges by preventing the unnecessary culling of billions of male chicks and reducing the waste of infertile eggs, while also creating new revenue streams. Beyond poultry, Orbem’s technology is versatile and applicable to sorting and quality control in nuts, seeds, plants, and other biological samples, enabling faster, more affordable, and accessible MRI-based scanning for food processing and other industries[1][2][3].
Founded in 2019 as a spin-off from the Technical University of Munich, Orbem emerged from years of scientific research at the intersection of AI and imaging technology. The founding team, led by CEO Pedro Gómez, a PhD expert in biomedical imaging, envisioned transforming traditional MRI—which is typically slow, expensive, and complex—into a fast, accessible tool powered by AI. Early recognition came through prestigious accolades such as the European Commission Seal of Excellence and being named the top deep tech startup worldwide in Food and Agriculture by Hello Tomorrow. The company has since grown rapidly, securing over €30 million in funding and expanding its product development and market reach[2][4][5].
Orbem rides the convergence of AI, imaging technology, and sustainable food production trends. The timing is critical as industries seek ethical, efficient, and data-driven solutions to reduce waste and improve animal welfare. Market forces such as increasing consumer demand for sustainable food systems and regulatory pressures against inhumane practices favor Orbem’s technology adoption. By transforming MRI into a practical industrial tool, Orbem is influencing the broader ecosystem by enabling new standards in food processing, quality control, and sustainability[1][2][3].
Looking ahead, Orbem is poised to expand its AI-powered imaging platform into new sectors such as construction and medical diagnostics, leveraging its hybrid cloud and on-premises infrastructure to scale efficiently. Trends in AI, sustainability, and automation will shape its journey, potentially making Orbem a key player in the future of industrial imaging and ethical food production. Its influence may grow as it sets new benchmarks for speed, affordability, and ethical impact in imaging technologies, driving a more sustainable and humane global food system[2][5].
Orbem has raised $32.0M across 1 funding round. Most recently, it raised $32.0M Series A in October 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 1, 2023 | $32.0M Series A | 83North, Accel, EQT Ventures, Flash Ventures, General Catalyst, Kreos Capital, La Famiglia, Octopus Ventures, Pareto Holdings, Picus Capital, Pi Labs, Vorwerk Ventures, Anselm Bauer, Benedikt Franke, Benjamin Guenther, Hanno Renner, Julius Göllner, Mario Götze, Max-Josef Meier, Michael Wax, Sebastian Schuon, Stefan Zuschke, Tao Tao, Thijn Lamers |